Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Intraoperative fluid infusion strategy remains controversial. Many animal model studies have shown that restricted fluid infusion reduces blood loss, though reports on this topic in humans are rare. The purpose of this study was to determine the effects on volume of blood loss of a restricted fluid infusion strategy for hepatectomy in donors for living donor liver transplantation.

Methods: A before-after study design was used with prospective consecutive data collection. A total of 22 patients who underwent living-donor hepatectomy were enrolled. Eleven patients who were managed before the implementation of restricted-volume fluid administration comprised the standard-volume group, and 11 who were evaluated after the implementation of the restricted-volume infusion strategy comprised the restricted-volume group. In the standard-volume group, the donors were given 10 ml x kg(-1) x h(-1) of lactated Ringer's solution and additional plasma expander corresponding to blood loss. In the restricted-volume group, the donors received 5 ml x kg(-1) x h(-1) of lactated Ringer's solution until the resection of the hepatic graft, followed by 15 ml x kg(-1) x h(-1) of lactated Ringer's solution after the completion of resection until the end of the operation.

Results: Intraoperative blood loss was less in the restricted-volume group (445 +/- 193 ml) than in the standard-volume group (1331 +/- 602 ml; P < 0.01). Intraoperative fluid infusion was also less in the restricted-volume group (4130 +/- 563 ml) than in the standard-volume group (5634 +/- 1260 ml; P < 0.01). There were no differences in length of hospital stay or side effects between the two groups.

Conclusion: Our restricted-volume strategy reduced blood loss and had no adverse effects during living-donor hepatectomy.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00540-008-0708-1DOI Listing

Publication Analysis

Top Keywords

fluid infusion
20
blood loss
20
infusion strategy
16
standard-volume group
16
restricted-volume group
16
restricted fluid
12
kg-1 h-1
12
h-1 lactated
12
lactated ringer's
12
ringer's solution
12

Similar Publications

Hypoalbuminemia is commonly seen in patients with heart failure and is associated with worse outcomes. Multiple pathophysiologic mechanisms can contribute to low albumin levels in heart failure patients, such as malnutrition, hepatic congestion, inflammation, and protein-losing enteropathy. Hypoalbuminemia can exacerbate heart failure symptoms and contributes to pulmonary edema by reducing plasma oncotic pressure, thereby favoring fluid movement into the interstitial and alveolar spaces.

View Article and Find Full Text PDF

Pathophysiology and treatment of exercise-associated hyponatremia.

J Endocrinol Invest

September 2025

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.

Exercise associated hyponatremia (EAH) is a medical condition that can occur during physical exertion. Initially, EAH was considered to be restricted to extreme endurance activities, such as ultramarathons and Ironman triathlons. However, it has been more recently recognized in a variety of sports, including team sports and in shorter-duration events.

View Article and Find Full Text PDF

Background: Transcranial electrical stimulation muscle-recorded motor evoked potentials (Tc-mMEPs) are used to monitor the spinal cord motor tracts during spinal surgery. There is considerable intra- and interindividual variability in the signals recorded, causing a high incidence of false positive warnings. Inadequate blood pressure is commonly blamed for false positive warnings and is usually managed with fluid and vasopressor therapy.

View Article and Find Full Text PDF

Secondary Infusion Underdelivery: Risks and Rewards of Common Workarounds.

AACN Adv Crit Care

September 2025

Nathaniel M. Sims is Research Faculty, Department of Anesthesia, Mass General Brigham (MGB). Associate Professor, Harvard Medical School. Newbower/Eitan MGH Endowed Chair in Biomedical Technology Innovation. Physician Advisor, MGB Biomedical Engineering, Boston, Massachusetts.

Secondary medication delivery using large-volume smart pumps offers important workflow and safety benefits. However, the widely used linear peristaltic large-volume smart pumps rely on sufficient head-height differential for accurate secondary infusion, leading to underdelivery risks. This article outlines common clinician workarounds used to mitigate these risks, including delivering secondary medications via primary mode, programming excess volume to be infused, clamping primary lines, and using short-set primary delivery.

View Article and Find Full Text PDF

Optimizing Patient Safety: Intravenous Smart Pump Usability in Acute and Critical Care.

AACN Adv Crit Care

September 2025

Dian Baker is Professor Emeritus, School of Nursing, California State University, Sacramento, California.

Large-volume intravenous (IV) smart pumps are used in acute and critical care to deliver IV fluids and medications with safety-enhancing features such as dose error reduction systems. Although these technologies offer improvements over manual administration, IV smart pumps are associated with high rates of medication errors, programming challenges, and usability issues. Alarm fatigue, interface complexity, and workarounds are common, with studies showing high error rates.

View Article and Find Full Text PDF